||Anne Beck is a registered nurse, working in a remote indigenous community for ISC (previously Health Canada First Nations & Inuit Health Branch). Her 30 year career consists of Emergency, Intensive Care, Cardiac Care, Sexual Assault, Public Health and Community Health Nursing. Anne's primary focus is Blood Borne Illnesses.|
|Dr. Ricardo Baptista Leite, MD, MP
||Member of the Portuguese Parliament (Health and the Foreign Affairs Committees), National Spokesperson for Health of the Social Democratic Party (PSD) and Head of Public Health at Católica University of Portugal. Founding President of ‘UNITE – Global Parliamentarians Network to End HIV/AIDS, viral hepatitis and other infectious diseases’. Vice President of the ‘Parliamentary Network on The World Bank & International Monetary Fund’. One of six people globally nominated by ‘The Economist Intelligence Unit’ (2016) as a ‘HCV Change Maker’ in recognition of leadership in the field of hepatitis c. Guest Lecturer at NOVA Information Management School and NOVA Medical School. Former Deputy Mayor and City Councilor of Cascais responsible for health, economic diplomacy and international relations. Prior to being elected MP, Dr. Baptista Leite worked as a practicing physician, including a 5-year Infectious Diseases residency program at the Western Lisbon Hospital Centre and an internship at the World Health Organization (Copenhagen). PhD candidate at Maastricht University, having completed post-graduate studies in multiple universities including Johns Hopkins University, Harvard Kennedy School of Government and Harvard Medical School.
Founder of ‘CREATING HEALTH – Research and Innovation Funding’ and Co-founder of the ‘Estoril Conferences’. Main author of the book ‘Citizenship for Health’, among other publications.
|Jennifer Broad||Jennifer Broad is a Community Support Worker with the Toronto Community Hep C Program where she co-facilitates treatment support groups and co-coordinates a research project evaluating peer-delivered point-of-care antibody outreach HCV testing. Jennifer has published and presented on the involvement of people with lived experience in HCV care both nationally and internationally.|
||A conscientious and experienced Nurse with 18 years viral hepatitis /hepatology experience, both in a community/countywide setting and including x2 tertiary referral centres in London, including Prisons.
My main focus for several years has been to improve patient experience amongst a wide range of service users and providers, and to develop innovative projects that will enable greater access to care for all patient/client groups.
||A/Prof Philip Cunningham directs the NSW State Reference Laboratory for HIV at St Vincent’s Hospital in Sydney. Established in 1982 the reference lab plays an important role in providing testing and surveillance to monitor the changing patterns of HIV and HCV infection in Australia.
Successfully implementing quality management programs in laboratories throughout the Asia Pacific region, his research interests include improving rates of HIV/HCV testing in key populations.
|Louisa Degenhardt||Louisa Degenhardt is a UNSW Scientia Professor, NHMRC Senior Principal Research Fellow and Deputy Director at the National Drug and Alcohol Research Centre (NDARC) at UNSW. Louisa conducts diverse epidemiological studies including data linkage studies focusing upon people with extra-medical or dependent opioid use or chronic pain, analysis of large-scale community and clinical surveys, and cohorts of young people. She is currently CI on a NHMRC Program Grant focussed on drug dependence and viral hepatitis in people who use drugs.|
||Prof John Dillon is Professor of Hepatology and Gastroenterology and a principle investigator, in the Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, based at Ninewells hospital, Dundee. He is also an Honorary Consultant with NHS Tayside, leading a busy general hepatology service and a research group.|
||Sadeem is a researcher with indigenouswellness.Ca. She works under the mentorship of Dr. Alexandra King and Dr. Malcolm King. She is pursuing a Masters in Public Health (MPH) at Simon Fraser University. Her research interests include Indigenous wellness and health, with focus on hepatitis C and HIV in Canadian contexts.|
|Heidi Friðriksdóttir||Ragnheidur (Heidi) Fridriksdottir is the project manager of the TrapHepC program in Iceland. With a background in nursing, clinical research and project management, Heidi has been responsible for the setup, management and day to day operations of the TrapHepC program - the largest preventative program in Iceland to date.|
||Lesley Gallagher is a clinical research nurse, working in Vancouver, at three inner city clinics, which have HCV treatment programs embedded into their primary care/addictions programs. She also works in Saskatoon, for the Saskatchewan Infectious Disease Care Network (SIDCN), providing Hepatitis C care within the urban centre and in northern and rural areas of the province. Lesley is the vice president and education director for the Canadian Association of Hepatology Nurses (CAHN) and represents CAHN, as a member of the steering committee for Action Hepatitis Canada (AHC). Lesley is a facilitator for the HCV Education Program, organized by The International Network on Hepatitis in Substance Users (INHSU), providing HCV training sessions for nurses and general practitioners in Canada.|
||Dr Janine Hardial is a Clinical Assistant Professor at UBC and a full-service family physician. She is also the Medical Coordinator at Sheway, a pregnancy outreach program in Vancouver's Downtown Eastside, a consultant physician for the provincial Perinatal Addiction Service and a maternity care provider at BC Women's Hospital|
||Catherine Hankins MD PhD FRCPC CM is Professor of Public and Population Health, McGill University. She co-founded CACTUS-Montreal in 1989 and received the International Harm Reduction Association’s 1994 National Rolleston Award for Harm Reduction. She was Chief Scientific Adviser to UNAIDS (2002-2012), leading its scientific knowledge translation team. She is Scientific Chair and Chair, Organising Committee of Africa’s annual INTEREST conference http://interestconference.org/.|
||Professor Margaret Hellard AM is a Deputy Director at the Burnet Institute. Margaret’s principal research interests are in preventing the transmission and improving the management of blood borne viruses, with the ultimate aim to end the AIDS epidemic and eliminate viral hepatitis as a public health threat.|
|Francisco Inacio Bastos
||I´m a physician with postgraduate studies in the field of psychiatry and epidemiology. I´ve been working in the field of substances use and misuse and associated harms and risks for more than 30 years. both as a clinician and a researcher.
I´ve published over 260 papers in peer-review journals, as well as pver 100 book chapters and books, both for professionals and for the lay public (Popular science)
|Sharon Jinkerson Brass||Sharon Jinkerson-Brass is a member of Key First Nation in Saskatchewan.
Sharon was part of the “sixties scoop” but she reunited with her family in the 1980’s. Sharon received her cultural teachings from her beloved Anishinabek grandmother Rebecca, who was a midwife and traditional healer. Sharon’s cultural heritage has inspired her way of living and being which in turn has informed her community work. Sharon is currently working on multiple research projects in the Down Town East Side Community for the Indigenous Wellness Research Team. Sharon believes that a relevant, sustainable cultural foundation is the key for wellness for her people and all people.
||Didier Jutras-Aswad is an addiction psychiatrist and researcher at the CHUM Research Centre. He is a Clinical Associate Professor at Université de Montréal and president of Université de Montréal’s Expertise and Collaboration Center on Concurrent Disorders. His research program focuses on addiction, HCV and comorbid psychiatric conditions.|
||Dr. John Kim is with the National HIV/AIDS Laboratories in Winnipeg, MB. They have recently engaged the original custodians of Turtle Island to expand access for testing blood borne infections using dried blood spots in a model that helps address empowerment, stigma, racism and health inequities associated with inadequate access to testing.|
||Dr. Alexandra King is the inaugural Cameco Chair in Indigenous Health at the University of Saskatchewan. She works with Indigenous communities and relevant stakeholders to understand the health and wellness of First Nations and Metis peoples in Saskatchewan and the structural changes needed for improved Indigenous health outcomes. Alexandra brings leadership skill in culturally safe and responsive research and care, Two-eyed Seeing and Ethical Space.|
|Niklas Luhmann||Niklas Luhmann is a medical doctor. He completed his Masters in Public Health at the University of Berlin in 2006. He has been working throughout ever since on access to healthcare of marginalized populations. In July 2019 he joined the Global Hepatitis Team at the WHO in Geneva.|
|Stéphanie Marsan||Dr Stéphanie Marsan is a clinical assistant professor and Program director of the addiction medicine specialty program at the Université de Montréal. She is also an attending physician in the addiction medicine service of the Centre hospitalier de l'Université de Montréal.|
||Renée is First Nation and presently Director of Research and Policy with the Canadian Aboriginal AIDS Network. She has dedicated her professional energies to Indigenous health with research interests focused on community-based research, Indigenous knowledge and health. She has contributed to Indigenous HIV/AIDS work with dedication and determination from 1995.|
||Håvard Midgard is a specialist in internal medicine and gastroenterology/hepatology at Oslo University Hospital. He has a PhD on management of HCV infection among PWID. His main research interests include HCV reinfection, models of HCV care, HCV epidemiology and elimination strategies, liver fibrosis assessment and management of advanced liver disease/cirrhosis complications. He is a board member of INHSU and hosted the 2016 INHSU Symposium in Oslo.|
|Gladys Mwende Ngwe
||Gladys is a Harm Reduction Nurse at Medecins Du Monde-France, Kenyan Program, with a wide knowledge and experience in implementing harm reduction intervention for people who use drugs with a specific focus for Women who use drugs. She holds a Bachelor of Science in Nursing and Public Health from Kenyatta University.|
||Marie Nougier is IDPC’s Head of Research and Communications. She also engages in networking, civil society capacity building activities, and policy advocacy engagement, especially at the UN, in Latin America (with a focus on gender) and Europe (as a Core Group member of the EU Civil Society Forum on Drugs).|
||Jose Quieroz is the Executive Director of APDES in charge of advocacy and capacity building. He advocates for: a) the recognition of Peer Work, b) Civil Society/State dialogues c) HR 100% funding in Portugal. Chair of the "1st Conference on Drug Policy in the PALOP" (Cape Verde) and Host of HRI19 Conference (Porto); member of the SC of the Correlation HRN. Leading the APDES engagement in the creation of the Portuguese Drug Users’ Union (CASO).|
|Sean Regan||Sean Regan is an Associate Director of Partnerships and Resource Mobilization on CHAI’s Global Hepatitis team and has been with CHAI for seven years. He is based in New York and currently supports work across all seven CHAI hepatitis program countries. In his role with the Global Hepatitis Team, Sean has guided partner governments through the launch of public hepatitis programs and worked with both public and private stakeholders to support scale-up efforts. In addition to hepatitis programming, Sean has held roles in health financing and new product introduction with CHAI. Through this work, he has gained extensive experience with commodity quantification, program costing, resource mapping, cost-effectiveness analysis and policy development. Before joining CHAI, Mr. Regan was a member of JP Morgan’s North America equity derivatives trading operation.|
|Jurgen Rehm||After completing a PhD in methodology and psychology, Dr. Rehm has worked in Public Health in various countries, currently as a Senior Scientist for the Centre for Addiction and Mental Health and as a professor at the University of Toronto, Canada; and the I.M. Sechenov First Moscow State Medical University in the Russian Federation. Dr. Rehm has been selected as one the most influential scientists in substance use research in various international rankings.|
|Lisa R. Metsch
||Dr. Metsch, a medical sociologist, is the Dean of the Columbia University School of General Studies and Professor of Sociomedical Sciences at Columbia University’s Mailman School of Public Health. Dr. Metsch’s current research focuses on testing intervention models to address prevention and treatment needs for persons living with and at risk for HIV/HCV and substance use disorders.|
||Dr. Schackman is the Saul P. Steinberg Distinguished Professor of Healthcare Policy & Research at Weill Cornell Medical College. He conducts research relating to economic evaluations of the comparative effectiveness of health interventions alongside clinical trials and cohort studies, cost-effectiveness and comparative effectiveness simulation modeling, and implementation science studies—particularly relating to treatment of infectious diseases and substance use disorders.|
|Andrew Scheibe||Dr Andrew Scheibe is a medical doctor by training who works in harm reduction research, programmes and policy in South Africa and the region. His work focuses on the intersections between infectious diseases, determinants of health and the rights of people who use drugs. He has been working in the field of harm reduction and substance use for the past eight years. He is a senior technical advisor for TB HIV Care and has research affiliations with the University of Pretoria’s Department of Family Medicine and the Urban Futures Centre at the Durban University of Technology.|
||Sidsel Sejr is a nurse and head of development and quality control, studying a master in Public Health (MPH). She has been working with people who uses drugs in ten years. In 2018 she implemented SACC in her organization (Shared Addiction Care Collaboration), which focus is to treat people with Hepatitis in-house in the OST clinics.|
||Sonjelle started her career in public health at a community-based health outreach organization in rural Ghana. She has over ten years of experience in programme implementation and research. Her time in Ghana cemented her dedication to public health approaches that are collaboratively designed and implemented with meaningful data capture.|
|Naglaa Shoukry||Dr. Shoukry is a leader in studying immunity to HCV in people who inject drugs. She is the Director of the Canadian Network on Hepatitis C (CanHepC) that is working towards establishing a pipeline from research to implementation and to improve the lives of Canadians living with HCV.|
|Sunil Solomon||Dr. Solomon is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. He is trained in medicine from India and received a MPH and Phd in Epidemiology from the Johns Hopkins University. His research interests include the strategies to improve the HIV and HCV care continue among key populations in low and middle income countries. He was elected into the Phi Beta Kappa honors society and one of the first recipients of the NIDA Avenir award aimed at identifying young researchers who show promise in the field of HIV and substance abuse.|
|Anne Spaulding||Dr. Spaulding obtained her M.D. from Medical College of Virginia and her M.P.H. through Johns Hopkins. Currently she is an associate professor at Emory University, Rollins School of Public Health, Atlanta GA. She has authored over 100 articles and letters, focusing on infectious diseases in jails and prisons.|
|Jack Stone||Dr Jack Stone is an infectious disease mathematical modeller based in Population Health Sciences at the University of Bristol. His work focuses on hepatitis C virus (HCV) and HIV transmission among high-risk populations, including people who inject drugs, female sex workers and men who have sex with men.|
||Tracy Swan has worked at community health centers, hospitals, prisons, shelters and at NSP, OAT and addiction treatment programs. She works with allies around the world to fight for evidence-based research and policies that create access to affordable, high-quality HCV prevention, diagnostics, care and treatment for PWID everywhere.|
||Jan Tait is Lead Clinical Nurse Specialist in Gastroenterology at Ninewells Hospital, Dundee, Scotland. She completed a BSc in Nursing at Queen Margaret’s University, Edinburgh and a MSc in Advanced Nursing Practice at Dundee University. She has provided a nurse-led hepatitis service for the last 20 years|
||Karla Thornton is a Professor of Infectious Diseases at the University of New Mexico and serves as an Associate Director of Project ECHO. She provides HCV care in the state prisons using the ECHO model and provides education about HCV and addiction in the prisons through her peer education program.|
||I am a Senior Consultant in Gastroenterology working at Changi General Hospital, Singapore. I have an interest in Hepatology having done my PhD in Hepatitis C immunogenetics at the Peninsula Medical School in the UK. I am currently Director of Hepatology at Changi General Hospital which has the largest catchment of Hepatitis C patients and serves the prison population in Singapore.|
||Dr. Tyndall is a Professor at the UBC School of Population and Public Health and the former Executive Director of the BC Centre for Disease Control. He is an infectious diseases specialist and epidemiologist with an interest in urban health, drug use and drug policy reform. He is an author on over 250 peer-reviewed publications, with a focus on HIV and Hepatitis C care and prevention.|
||Peter Vickerman is a Professor in infectious disease modelling with 20 years experience. His research focuses on using modelling the transmission of infectious diseases and impact/cost-effectiveness of prevention measures amongst key populations, especially HIV and HCV among people who inject drugs.|
|Ernst Wisse||With a background as a nurse, Ernst has experience as a fieldworker in several low-threshold street-based programs, he increasingly got involved in project management of Harm Reduction interventions in low and middle income countries in the middle east and Asia like Iran, Afghanistan and Myanmar.|